Mark Swanson

Corporate Officer/Principal bij Gel Med Sciences, Inc.

Health Technology

Consumer Services

Commercial Services

Actieve functies van Mark Swanson

Bedrijven	Functie	Begin	Einde
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Corporate Officer/Principal	-	-
	Hoofd Techniek/Wetenschap/O&O	04-01-2010	-

Bedrijven	Functie	Begin	Einde
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Corporate Officer/Principal	-	-
Sandoz Pharmaceuticals Corp.	Hoofd Techniek/Wetenschap/O&O	-	-

University of Connecticut

Doctorate Degree

Internationaal

Verenigde Staten

Operationeel

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	3
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Health Technology
Sandoz Pharmaceuticals Corp.
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Commercial Services